Monday morning in Europe opened with a touch of restraint. Investors are deferring major moves as they await pivotal news: a meeting in Washington between President Trump, Ukrainian leader Zelenskiy, and several European heads of state—talks that could reshape the market’s geopolitical backdrop.
Despite firm footing from last week, most European indexes held steady. The STOXX 600 hovered in neutral territory, while Germany’s DAX eased modestly. The air was thick with anticipation—across energy, defense, and building stocks, firms are poised for fate-changing headlines.
Parallel attention turned toward Jackson Hole, where Fed Chair Powell will speak later this week. Traders are bracing for potential shifts in monetary policy that could impact capital flows and sentiment.
Yet, amid the broader calm, pockets of activity emerged. Vestas surged on the back of clarity in U.S. renewable energy policies, and Novo Nordisk gained steam following FDA approval for its weight-loss therapy aimed at liver disease.
In short, Europe’s markets are adopting a “wait-and-see” posture—balancing hope, caution, and sharp trading on newsworthy exceptions.
No comments:
Post a Comment